Janssen Pharmaceutical Companies of Johnson & Johnson to Exhibit at 2011 BIO International Convention, June 27 - 30, 2011

TITUSVILLE, N.J.--(BUSINESS WIRE)-- Press Kit Materials are Available at: http://www.tradeshownews.com/events/2011-BIO-International-Convention/janssen/

Company:

  Janssen Pharmaceutical Companies of Johnson & Johnson
Event:

2011 BIO International Convention
June 27 - 30, 2011
Washington DC, US

Web:

http://www.janssenpharmaceuticalsinc.com/

About Janssen Pharmaceutical Companies of Johnson & Johnson

The Janssen Pharmaceutical Companies are dedicated to addressing and solving the most important unmet medical needs of our time. Our people, across many different companies, are united in their passionate pursuit of science for the benefit of patients. With employees in over 50 countries, we are working to bring innovative ideas, products and services to patients throughout the world.



CONTACT:

PR Contact
Porter Novelli
Virginia Amann, 608-207-0082
[email protected]

KEYWORDS:   United States  North America  District of Columbia  New Jersey

INDUSTRY KEYWORDS:   Health  Biotechnology  Pharmaceutical  Other Health

MEDIA:

Suggested Articles

While the failure might be a missed chance at revenue, it shouldn’t hurt Ibrance’s ability to rack up sales in the metastatic setting, one exec says.

Patients receiving Bavencio actually did worse than those who got placebo, increasing the risk of death by 31%.

Seattle Genetics and Astellas’ newcomer Padcev now has what every cancer drugmaker is looking for: Randomized trial data showing it can extend lives.